Azitra, Inc.
AMEX:AZTRBiotechnology
+$0.82 today
- Market cap
- $92.72M
- Beta
- -1.04
- P/E (TTM)
- -1.2
- EPS (TTM)
- -$0.64
Volume 146.25M
Average 11.12M
AZTR Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Azitra, Inc.AMEX: AZTR
Total Assets · Q2 FY2026 · quarter ended Jun 2026
Total assets rises 125.4% from a year ago
Total assets stood at $8.92M at the end of Q2 FY2026, up 125.4% from a year earlier and down 26.5% from the prior quarter. Over 3 fiscal years it compounded at -11.2% a year.
Context
- Total assets increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total assets keeps rising in the next quarterly balance sheet after a +125.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
USD · from the balance sheet
- Latest · FY2025
- 5.03M USD
- Year-over-year change
- -31.7%
- 4-year CAGR
- -16.2%
| Period | Period end | Total Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.03M | -31.7% |
| FY2024 | 2024-12-31 | 7.36M | +43.9% |
| FY2023 | 2023-12-31 | 5.12M | -28.6% |
| FY2022 | 2022-12-31 | 7.17M | -29.7% |
| FY2021 | 2021-12-31 | 10.2M | — |
Total Assets vs competitors
How AZTR compares with its peers on the latest reported figures
- AZTR's Jun 2026 total assets of $8.92M is the highest of the 2 companies compared; the peer median is $2.18M.
- Its year-over-year change of +125.4% is the highest of 2, against a peer median of -59.7%.
- Over three fiscal years its annual growth of -11.2% compares with a peer median of -30.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Jun 2026 | $8.92M | +125.4% | -11.2% | |
| Mar 2026 | $2.18M | -59.7% | -30.8% | |
| Peer median (excluding AZTR) | $2.18M | -59.7% | -30.8% | |
Competitors are the stored peer set for AZTR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 8.04M | 3.49M | 1.8M | 4.55M | 2.07M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 334.18K | 266.21K | 223.47K | 101.9K | 141.3K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 216.89K | 67.86K | 4.11K | 0 |
| Total Current Assets | 8.49M | 4.14M | 2.54M | 5.23M | 3.02M |
| Property, Plant & Equipment (Net) | 946.68K | 1.96M | 1.58M | 1.21M | 962.08K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 97.69K | 219.57K | 210.88K | 246.42K | 316.67K |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 668.23K | 848.34K | 789.99K | 678.22K | 727.31K |
| Total Non-current Assets | 1.71M | 3.03M | 2.58M | 2.13M | 2.01M |
| Total Assets | 10.2M | 7.17M | 5.12M | 7.36M | 5.03M |
| Account Payables | 717.8K | 784.69K | 897.27K | 490.26K | 399.36K |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 1.3K | 0 | 0 | 11.57K | 6.26M |
| Deferred Revenue | 15K | 156K | 0 | 0 | 0 |
| Other Current Liabilities | 43.47K | 27.08K | 145.04K | 32.97K | 236.86K |
| Total Current Liabilities | 1.21M | 2.22M | 1.6M | 1.38M | 1.07M |
| Long-term Debt | 992.02K | 6.6M | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 33.77M | 33.76M | 35.45K | 381 | 0 |
| Total Non-current Liabilities | 34.76M | 41.21M | 599.15K | 284.65K | 156.19K |
| Total Liabilities | 35.97M | 43.43M | 2.2M | 1.66M | 1.22M |
| Common Stock | 104 | 104 | 1.21K | 763 | 1.07K |
| Retained Earnings | (26.63M) | (37.31M) | (48.6M) | (57.57M) | (68.52M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | (25.77M) | (36.26M) | 2.91M | 5.7M | 3.8M |
| Total Debt | 992.02K | 7.73M | 885.95K | 555.51K | 422.08K |
| Net Debt | (7.05M) | 4.24M | (910.04K) | (4M) | (1.65M) |
Azitra, Inc.
AMEX:AZTR
Intrinsic Alpha fair value
Locked
Current Price
$1.53
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.